Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	507.2	529.8	488.1	403.8	434.22	470.78
Short-Term Investments	1,058	1,011	1,176	1,203	1,356	399.14
Cash & Short-Term Investments	1,565	1,541	1,665	1,607	1,791	869.92
Cash Growth	-5.76%	-7.44%	3.57%	-10.25%	105.84%	-12.23%
Accounts Receivable	426.2	460.6	452.5	489	494.65	423.54
Other Receivables	13.3	11.9	13.1	11.9	11.6	2.2
Receivables	439.5	472.5	465.6	500.9	506.25	425.74
Inventory	770.5	740.7	760	780.5	719.32	572.24
Prepaid Expenses	150	136.5	122.6	140	124.18	109.14
Restricted Cash	1.6	2	1.4	0.2	0.01	0.01
Other Current Assets	15.8	13.8	16.2	19.6	17.55	13.44
Total Current Assets	2,942	2,906	3,030	3,048	3,158	1,990
Property, Plant & Equipment	689.4	709.9	688.6	723.7	679.56	716.44
Long-Term Investments	5,311	6,103	4,838	7,697	8,830	14,386
Goodwill	577.1	579.8	410.5	413.6	406.49	347.34
Other Intangible Assets	166.8	174.3	293.6	320.5	332.15	253.94
Other Long-Term Assets	103.9	103.8	103.5	96.4	95.8	105.49
Total Assets	9,790	10,577	9,364	12,299	13,502	17,799
Accounts Payable	133.1	129	122.3	144.6	135.04	141.94
Accrued Expenses	148.4	172.3	124.2	139.9	194.79	312.97
Current Portion of Long-Term Debt	400	0.8	0.8	-	-	-
Current Portion of Leases	36.7	36.6	42.1	40.9	36.8	36.92
Current Income Taxes Payable	44.9	36.6	31.2	35.8	32.43	10.32
Current Unearned Revenue	56.3	48.9	47.8	-	-	50.85
Other Current Liabilities	97.6	92.8	99.4	161.6	169.65	127.94
Total Current Liabilities	917	517	467.8	522.8	568.71	680.94
Long-Term Debt	794.3	1,193	1,191	1,190	1,188	0
Long-Term Leases	147.2	154.4	140.6	175.1	163.73	186.45
Long-Term Unearned Revenue	13.6	14	13.7	-	-	-
Pension & Post-Retirement Benefits	-	49.2	56.9	59.5	45.3	73.8
Long-Term Deferred Tax Liabilities	881.8	1,059	818	1,476	1,770	3,065
Other Long-Term Liabilities	184.8	135.9	106.6	135.5	150.61	108.39
Total Liabilities	2,939	3,123	2,795	3,558	3,886	4,114
Common Stock	-	-	-	-	0	0
Additional Paid-In Capital	490.5	476	463.2	449.1	447.45	441.73
Retained Earnings	7,649	8,176	7,416	9,261	9,898	13,525
Treasury Stock	-1,053	-1,010	-772.1	-632.5	-263.59	-106.29
Comprehensive Income & Other	-235.4	-189.1	-538.2	-336	-466.82	-175.55
Shareholders' Equity	6,851	7,454	6,569	8,741	9,615	13,685
Total Liabilities & Equity	9,790	10,577	9,364	12,299	13,502	17,799
Total Debt	1,378	1,385	1,375	1,406	1,388	223.38
Net Cash (Debt)	186.5	155.9	289.8	201.6	402.56	646.54
Net Cash Growth	-35.89%	-46.20%	43.75%	-49.92%	-37.74%	-15.53%
Net Cash Per Share	6.90	5.71	10.27	6.90	13.52	21.40
Filing Date Shares Outstanding	26.76	26.99	28.01	28.52	29.6	29.93
Total Common Shares Outstanding	26.83	26.99	28.01	28.52	29.6	29.93
Working Capital	2,025	2,389	2,563	2,526	2,589	1,310
Book Value Per Share	255.37	276.16	234.52	306.51	324.89	457.20
Tangible Book Value	6,107	6,700	5,865	8,007	8,877	13,084
Tangible Book Value Per Share	227.65	248.22	209.39	280.77	299.93	437.12
Land	-	28.9	27.8	28.4	27.8	27.94
Buildings	-	449.4	426.3	419.8	393.6	385.8
Machinery	-	1,323	1,183	1,148	1,087	1,100

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error